Stockscreener 앱 받기
3.15
1.87%
-0.06
시간 외 거래:
3.15
전일 마감가:
$3.21
열려 있는:
$3.22
하루 거래량:
442.39K
Relative Volume:
0.36
시가총액:
$261.73M
수익:
-
순이익/손실:
$-36.95M
주가수익비율:
-3.75
EPS:
-0.84
순현금흐름:
$-33.46M
1주 성능:
-6.53%
1개월 성능:
-5.41%
6개월 성능:
-15.32%
1년 성능:
-3.67%
1일 변동 폭
$3.145
$3.28
1주일 범위
$3.145
$3.48
52주 변동 폭
$1.61
$5.37
Larimar Therapeutics Inc Stock (LRMR) Company Profile
명칭
Larimar Therapeutics Inc
전화
844-511-9056
주소
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA
Compare LRMR vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LRMR
Larimar Therapeutics Inc
|
3.15 | 266.72M | 0 | -36.95M | -33.46M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Larimar Therapeutics Inc Stock (LRMR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-29 | 개시 | Truist | Buy |
| 2024-10-16 | 개시 | Oppenheimer | Outperform |
| 2024-10-03 | 개시 | Wedbush | Outperform |
| 2024-10-02 | 개시 | H.C. Wainwright | Buy |
| 2024-09-04 | 개시 | Robert W. Baird | Outperform |
| 2024-04-03 | 개시 | Leerink Partners | Outperform |
| 2023-11-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-10-19 | 개시 | Guggenheim | Buy |
| 2022-02-15 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-02-10 | 개시 | JMP Securities | Mkt Outperform |
| 2021-02-01 | 개시 | William Blair | Outperform |
모두보기
Larimar Therapeutics Inc 주식(LRMR)의 최신 뉴스
Is Larimar Therapeutics Inc. being accumulated by smart moneyQuarterly Portfolio Summary & Verified Technical Trade Signals - mfd.ru
Does Larimar Therapeutics Inc. have a sustainable dividendWeekly Investment Report & Smart Investment Allocation Insights - mfd.ru
Gap Down: Will Larimar Therapeutics Inc benefit from geopolitical trendsJuly 2025 Drop Watch & Consistent Return Strategy Ideas - baoquankhu1.vn
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Guidance Update: Does Larimar Therapeutics Inc have consistent dividend growthJuly 2025 Setups & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Geopolitics Watch: Is Larimar Therapeutics Inc. being accumulated by smart money2025 Price Momentum & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Portfolio Update: Is Smith Douglas Homes Corp a cyclical or defensive stockQuarterly Risk Review & Verified Short-Term Trading Plans - baoquankhu1.vn
Larimar Therapeutics executes strategic stock exchange agreement - MSN
Larimar’s Pediatric Friedreich’s Ataxia Trial Termination: What Investors Should Know - TipRanks
Friedreich's Ataxia Pipeline 2025: FDA Approvals and Clinical - openPR.com
AIGH Capital Management LLC Takes $3.23 Million Position in Larimar Therapeutics, Inc. $LRMR - MarketBeat
We Think Larimar Therapeutics (NASDAQ:LRMR) Needs To Drive Business Growth Carefully - Sahm
Head-To-Head Survey: Oncology Pharma (OTCMKTS:ONPH) vs. Larimar Therapeutics (NASDAQ:LRMR) - Defense World
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Larimar Therapeutics: The Market Is Mispricing A Potential Standard Of Care (NASDAQ:LRMR) - Seeking Alpha
Aug Gainers: What risks investors should watch in Larimar Therapeutics Inc stockQuarterly Profit Summary & Low Risk Entry Point Guides - Bộ Nội Vụ
Published on: 2026-01-14 08:49:57 - Bộ Nội Vụ
Death Cross: How Larimar Therapeutics Inc stock performs during Fed tightening cyclesM&A Rumor & Risk Adjusted Buy and Sell Alerts - Bộ Nội Vụ
Published on: 2026-01-13 20:02:33 - Bộ Nội Vụ
Aug Intraday: Will Larimar Therapeutics Inc. stock outperform value stocks2025 Technical Patterns & Risk Adjusted Buy/Sell Alerts - Bộ Nội Vụ
Published on: 2026-01-13 12:38:02 - moha.gov.vn
Volatility Watch: Does Larimar Therapeutics Inc have a sustainable dividendTrade Risk Assessment & AI Forecast Swing Trade Picks - baoquankhu1.vn
Will Larimar Therapeutics Inc. stock outperform value stocksTrade Volume Summary & Pattern Based Trade Signal System - ulpravda.ru
Contact | Statesman-ExaminerLarimar Therapeutics, Inc.Common Stock (Nasdaq:LRMR) Detailed Stock Data - FinancialContent
Why Larimar Therapeutics Inc. stock remains resilientRate Cut & AI Powered Market Entry Strategies - Улправда
Larimar Therapeutics Advances Friedreich’s Ataxia Program with New Publications on Nomlabofusp Data - MSN
How Larimar Therapeutics Inc. (ZA71) stock trades after rate cutsMarket Volume Report & Low Risk Entry Point Tips - ulpravda.ru
Will Larimar Therapeutics Inc. (ZA71) stock see valuation expansionWeekly Gains Summary & Weekly Watchlist for Hot Stocks - Улправда
Why Larimar Therapeutics Inc. (ZA71) stock could outperform next yearPortfolio Value Report & Risk Adjusted Buy and Sell Alerts - Улправда
How Larimar Therapeutics Inc. (ZA71) stock correlates with oil marketsRisk Mitigation Techniques & Affordable Market Strategies - ulpravda.ru
Larimar Therapeutics (NASDAQ:LRMR) Raised to "Strong-Buy" at Leerink Partnrs - MarketBeat
How buybacks impact Larimar Therapeutics Inc. stock value2026 world cup usa national team third place match young talents high defensive line group prediction breakdown - Улправда
Leerink Partners assumes coverage on Larimar Therapeutics stock with Outperform rating - Investing.com Canada
Short Interest in Larimar Therapeutics, Inc. (NASDAQ:LRMR) Decreases By 19.2% - MarketBeat
Why Larimar Therapeutics Inc. stock could rally in 2025Quarterly Portfolio Summary & Safe Entry Trade Reports - moha.gov.vn
Comparing Altimmune (NASDAQ:ALT) & Larimar Therapeutics (NASDAQ:LRMR) - Defense World
Larimar heads to JPMorgan as rare disease program draws investor attention - MSN
Larimar Heads to JPMorgan as Rare Disease Program Draws Investor Attention - MyChesCo
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Should I hold or sell Larimar Therapeutics Inc. stock in 20252025 Sector Review & Smart Money Movement Tracker - Улправда
How institutional buying supports Larimar Therapeutics Inc. stockJuly 2025 Update & Reliable Intraday Trade Plans - Улправда
Is Larimar Therapeutics Inc. stock a contrarian buyInsider Buying & Daily Technical Stock Forecast Reports - Улправда
Moving Averages: Can Larimar Therapeutics Inc. stock rebound after recent weakness2025 Earnings Surprises & Accurate Technical Buy Alerts - Улправда
Market Fear: How Larimar Therapeutics Inc. (ZA71) stock correlates with oil marketsJuly 2025 Outlook & Precise Swing Trade Entry Alerts - Улправда
Published on: 2025-12-20 00:54:00 - Улправда
Why Larimar Therapeutics Inc. stock appeals to analysts2025 Stock Rankings & Risk Controlled Stock Alerts - bolumsonucanavari.com
Published on: 2025-12-19 13:18:47 - ulpravda.ru
Published on: 2025-12-19 05:26:13 - Улправда
Is Larimar Therapeutics Inc. (ZA71) stock a buy during volatile marketsPrice Action & Comprehensive Market Scan Insights - Улправда
Why Larimar Therapeutics Inc. stock remains on buy lists2025 Sector Review & Risk Managed Investment Strategies - Улправда
Larimar Therapeutics Inc (LRMR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.12%
0.87%
자본화:
|
볼륨(24시간):